REPLICEL LIFE SCIENCES INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0428 USD | +4.99% |
|
-.--% | -4.89% |
| Apr. 18 | RepliCel Life Sciences Inc. Announces Secured Loan Agreement | CI |
| 2023 | RepliCel Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Performance
| 1 day | +4.99% | ||
| 3 months | -11.39% | ||
| 6 months | -38.86% | ||
| Current year | -4.89% | ||
| 1 year | -54.18% | ||
| 3 years | -85.37% | ||
| 5 years | -82.88% | ||
| 10 years | -99.30% |
Volumes
marketsDaily volume
550
Estimated daily volume
1 592
Record volume 1
429 181
Record volume 2
382 627
Record volume 3
315 643
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
2 784 341
Net sales ()
0
Number of employees
1
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
39.48 %
Free-Float capitalization (USD)
1 038 743
Highs and lows
Current year
0.03
0.07
1 year
0.030.19
3 years
0.030.35
5 years
0.030.47
10 years
0.036.60
Indicators
Moving average 5 days
0.04
Moving average 20 days
0.04
Moving average 50 days
0.05
Moving average 100 days
0.05
Price spread / (MMA5)
+1.32%
Price spread / (MMA20)
-7.09%
Price spread / (MMA50)
+5.29%
Price spread / (MMA100)
+16.49%
RSI 9 days
50.91
RSI 14 days
50.12
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +4.99% | -.--% | -4.89% | -54.18% | 2.78M | ||
| +0.98% | -1.05% | -2.54% | +14.95% | 102B | ||
| +0.93% | -0.86% | +2.33% | +11.41% | 96.09B | ||
| +0.66% | +4.06% | +2.13% | +0.60% | 22.28B | ||
| -1.49% | -0.64% | -17.07% | -21.85% | 21.4B | ||
| +0.46% | -2.12% | -8.79% | -29.65% | 18.14B | ||
| -2.02% | +3.73% | -39.98% | -35.33% | 17.02B | ||
| +1.24% | +7.84% | -13.83% | -40.22% | 16.09B | ||
| +1.37% | +0.86% | +6.38% | +34.74% | 13.83B | ||
| +0.72% | +2.89% | +32.58% | +2.19% | 11.97B | ||
| -3.13% | +19.23% | +316.87% | +250.72% | 8.78B | ||
| -2.90% | -6.69% | -29.95% | -37.31% | 7.96B | ||
| +1.52% | -2.05% | +11.35% | +61.69% | 7.91B | ||
| -0.21% | +1.74% | +0.54% | +36.20% | 7.76B | ||
| -1.58% | +7.34% | -53.58% | -70.42% | 7.31B | ||
| -9.48% | -10.29% | -11.34% | +12.96% | 6.92B | ||
| Average | -0.52% | +2.49% | +11.89% | +8.53% | ||
| Weighted average by Cap. | +0.17% | -0.09% | +3.37% | +8.57% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -4.81% | ||
| 2023 | -12.45% | ||
| 2022 | -71.65% | ||
| 2021 | +6.58% | ||
| 2020 | -22.58% | ||
| 2019 | -17.03% | ||
| 2018 | -14.58% | ||
| 2017 | -56.34% | ||
| 2016 | -63.21% | ||
| 2015 | -40.43% | ||
| 2014 | -34.55% | ||
| 2013 | +7.61% | ||
| 2012 | -80.43% | ||
| 2011 | +34.29% | ||
| 2010 | +12.90% |
- Stock Market
- Equities
- REPCF Stock
- Quotes RepliCel Life Sciences Inc.
